SC‐560 and mofezolac isosteres as new potent COX‐1 selective inhibitors with antiplatelet effect
Sign Up to like & getrecommendations! Published in 2023 at "Archiv der Pharmazie"
DOI: 10.1002/ardp.202200549
Abstract: Selective cyclooxygenase (COX)‐1 inhibitors can be employed as potential cardioprotective drugs. Moreover, COX‐1 plays a key role in inflammatory processes and its activity is associated with some types of cancer. In this work, we designed… read more here.
Keywords: new potent; cox; potent cox; mofezolac isosteres ... See more keywords